Flexogan Sport Ultra
Natural health product licensed in Canada
- Licence holder
- AlphaRx Canada Limited
- NPN or DIN-HM
- 02246439
- Status
- Inactive licence
- Licence date
- 23 October 2007
- Revision date
- Not provided
- Form
- Émulsion
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Salicylate de méthyle | 16 % |
Non-medicinal ingredients
Tocopheryl Acid Succinate, polyethylene glycol ether lanolin alcohol, Polyoxyl 35 Castor Oil, Glycérine, triéthanolamine, Bronopol, acétate de tocophéryle, Carbomère, Edetate Disodium, triglycérides à chaînes moyennes, Lécithine, Alcool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 g ; maximum: 2 g | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Enfants | minimum: 2 years | minimum: 1 g ; maximum: 2 g | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Flexogan Sport Ultra is a deep penetrating emulsion scientifically formulated to provide fast, effective and temporary relief from: Arthritis, Joint and Muscle Pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Avoid contact with the eyes and mucous membranes. Do not bandage. Do not apply to wounds or damaged skin. Do not use this product if you allergic to salicylates or if you are taking anti-coagulant medication. If rash, or irritation occurs, discontinue use. The applicatoin of external heat, such as electric heating pad, may result in excessive skin irritation or skin burn.
Source
Official Health Canada record, licence 02246439
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.